Stockreport

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Geneva, Switzerland, September 4, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel sma [Read more]